Generics Drugs Market Research Reports & Industry Analysis
The Federal Drug Administration (FDA) does not allow a generic firm to duplicate exactly the brand name formula. The generic manufacturer must alter the ingredients slightly. This is accomplished by adding inert substances, substances that are inactive, to the generic alternative. Inert substances may function as disintegrates, binders, fillers, drying agents, lubricants, coatings, wetting agents, flavorings, coloring, or drying agents. Generic drugs are often up to 50 to 80 percent cheaper than their brand name counterpart and are gaining in popularity among cost-conscious consumers and their third-party payers.
Generic drugs enter into the retail prescription industry in a two-step process. The exclusive patent protection for the brand name product must expire. As a brand name product nears patent expiration, generic competitors apply for approval to the FDA using an Abbreviated New Drug Application (ANDA). Duplicating studies of the original brand name drug is no longer required by the FDA, and many generic companies contract with specialty laboratories to conduct the bioequivalency studies regarding absorption rates. Although the majority of products must meet bioequivalence standards, bronchodilators and topical drugs cannot be measured by absorption rates and are exempt. Injectables do not require biostudies, and oral liquids are reviewed on an individual basis. The drug must receive FDA approval following this rigid testing. The FDA also conducts periodic plant site inspections and surveillance of quality control procedures.
Generics Drugs Industry Research & Market Reports
-
Active Pharmaceutical Ingredient (API) Market by type (Innovative, generic), manufacturer (captive, merchant), synthesis (synthetic, biotech), by product (vaccines, Hormones), drug (OTC, Rx), application (Diabetes, oncology, CVD) - Global Forecast to 2025
... pharmaceutical ingredients market is projected to reach USD 248.3 billion by 2025 from USD 187.3 billion in 2020, at a CAGR of 5.8% during the forecast period. Growth in the active pharmaceutical ingredients market is ... Read More
-
Generics BRIC (Brazil, Russia, India, China) Industry Guide 2015-2024
... profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights Brazil, Russian Federation, India and China (BRIC) are the emerging and fast growing ... Read More
-
Generics North America (NAFTA) Industry Guide 2015-2024
... contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights The North American Free Trade Agreement (NAFTA) is a trade agreement between the countries in ... Read More
-
Generics Global Industry Almanac 2015-2024
... the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) ... Read More
-
Generics Global Group of Eight (G8) Industry Guide 2015-2024
... profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights The G8 countries contributed $193,301.1 million in 2019 to the global generics industry, ... Read More
-
Generics Global Industry Guide 2015-2024
... the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) ... Read More
-
Generics Top 5 Emerging Markets Industry Guide 2015-2024
... profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights These countries contributed $99,860.0 million to the global generics industry in 2019, with ... Read More
-
Generic and Biosimilar Pharmaceuticals (GLOBAL) - Industry Report
... on the top 1110 companies, including ABBOTT LABORATORIES, ABBOTT LABORATÓRIOS, LDA and ACG LUKAPS D.O.O.. This report covers activities such as pharmaceuticals, drugs, medicines, pills, healthcare and includes a wealth of information on the financial ... Read More
-
Global Branded Generics Market Research Report 2020-2024
... epidemic, it will have a big influence on this market. Branded Generics Report by Material, Application, and Geography – Global Forecast to 2023 is a professional and comprehensive research report on the world’s major regional ... Read More
-
Generic Drugs Companies in China
... of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the ... Read More
-
Global Generic Pharmaceutical Partnering Terms and Agreements 2010-2020
... deals. This report provides details of the latest Generic Pharmaceutical agreements announced in the life sciences since 2010. The report takes the reader through a comprehensive review Generic Pharmaceutical deal trends, key players, top deal ... Read More
-
Generic Drugs Industry Forecasts - China Focus
... the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, ... Read More
-
Generic Drugs Markets in China
... economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic ... Read More
-
Global Generic Active Pharmaceutical Ingredients Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
... forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. ... Read More
-
Global Generic Drugs Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
... segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and ... Read More
-
Anti-Viral Therapies Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Type (Generic Drugs, Branded Drugs); Mechanism of Action (Nucleotide Polymerase Inhibitor, Reverse Transcriptase Inhibitors, Protease Inhibitors, Others); Application (H
... Influenza, Herpes, Other Applications) and Geography The global anti - viral therapies market is expected to reach US$ 76,282.63 million by 2027 from US$ 40,589.79 million in 2019; it is estimated to grow at a ... Read More
-
Global Inhalation & Nasal Spray Generic Drugs Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
... global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market ... Read More
-
Generics in Canada
... leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug ... Read More
-
Generics in Mexico
... leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug ... Read More
-
Generics in China
... leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug ... Read More
-
Generics in India
... leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug ... Read More
-
Generics in Indonesia
... leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug ... Read More
-
Generics in Japan
... leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug ... Read More
-
Generics in Russia
... leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug ... Read More
-
Generics in Germany
... leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug ... Read More
